Atara Biotherapeutics
ATRA
ATRA
84 hedge funds and large institutions have $493M invested in Atara Biotherapeutics in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.08% more ownership
Funds ownership: 3.22% → 3.3% (+0.08%)
1% less funds holding
Funds holding: 85 → 84 (-1)
Holders
84
Holding in Top 10
2
Calls
$540K
Puts
$261K
Top Buyers
| 1 | +$35.2M | |
| 2 | +$12.5M | |
| 3 | +$11M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.62M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.5M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$6.75M | |
| 3 | -$6.75M | |
| 4 |
TA
Teachers Advisors
New York
|
-$1.88M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.55M |